What is Rapport Therapeutics, Inc.'s free cash flow yield?

Rapport Therapeutics, Inc. (RAPP) reported free cash flow yield of -5.4% in Q1 2026.

How has Rapport Therapeutics, Inc.'s free cash flow yield changed year-over-year?

Rapport Therapeutics, Inc.'s free cash flow yield increased by 71.4% year-over-year, from -18.9% to -5.4%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Rapport Therapeutics, Inc. RAPP Free cash flow yield

Free cash flow yield at other companies

Bristol-Myers SquibbBMY

9.6%-0.9pp

Supernus PharmaceuticalsSUPN

10.5%-0.1pp

Xenon PharmaceuticalsXENE

-5.5%-1.2pp

Praxis Precision Medicines, Inc.PRAX

-3.1%-1.4pp

BiohavenBHVN

-46.7%+153pp

Septerna, Inc.SEPN

12.3%—

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.91B+309%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Calculated from Rapport Therapeutics, Inc.’s reported figures.

free cash flow/market cap=-5.4%

Based on trailing twelve months.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s free cash flow yield?: Rapport Therapeutics, Inc. (RAPP) reported free cash flow yield of -5.4% in Q1 2026.
How has Rapport Therapeutics, Inc.'s free cash flow yield changed year-over-year?: Rapport Therapeutics, Inc.'s free cash flow yield increased by 71.4% year-over-year, from -18.9% to -5.4%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.